IGEA Pharma

IGEA Pharma Focuses on Health Technology and Medical Technology Products and Equipment. Health Technology Products Are Entirely Preventive. IGEA Has Commercialized Alzheimer's Prevention Solutions (Including "Alz1," a Home Laboratory Test Kit for Measuring Unbound Copper in Blood, and "Alz1 Tab," a Natural Dietary Supplement Designed to Reduce Heavy Metal Content in Blood), and Is Expected to Launch a Type 2 Diabetes Prevention Solution in 2020. Non-ceruloplasmin-bound Copper is a Biomarker Associated with Alzheimer's and Type 2 Diabetes. Identifying and Regulating Unbound Copper Helps Reduce the Risk of Alzheimer's and Type 2 Diabetes.